<a target="_blank" href="https://ascopubs.org/doi/10.1200/JCO.2010.28.7078">Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up</a><a target="_blank" href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2848408">GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy</a>* Previously discussed on Fornight XXII: <a target="_blank" href="https://www.bmj.com/content/392/bmj-2025-086886">Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study</a> This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.sensible-med.com/subscribe?utm_medium=podcast&#38;utm_campaign=CTA_2">www.sensible-med.com/subscribe</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

This Fortnight in Medicine XXVII

Sensible Medicine

AI Chapters

AI Insights

Reviews